Zobrazeno 1 - 10
of 115
pro vyhledávání: '"S, Nisam"'
Autor:
S. Nisam
Publikováno v:
Herzschrittmachertherapie und Elektrophysiologie. 10:S008-S014
Die therapeutische Effizienz implantierbarer Defibrillatoren bei Patienten mit lebensbedrohlichen ventrikularen Tachyarrhythmien ist inzwischen erwiesen. Daher ruckt die Kosteneffizienz dieser Therapieform immer mehr in den Mittelpunkt. Studien zur K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71fef718e6e7a8bb1cbb34a42df7523c
https://doi.org/10.1007/s003990050103
https://doi.org/10.1007/s003990050103
Autor:
S. Nisam, M. Brignole
Publikováno v:
Cardiac Arrhythmias 2005 ISBN: 8847003709
Are the appropriate indications for ICDs (based on clinical evidence) limited by health care system resources? An overview of the number of ICD (including CRT-D) implants and their costs in USA, Europe, and Italy in 2003 and 2004 is provided in Table
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e18a60e6838c97bec0fc4486fd10ad9
https://doi.org/10.1007/88-470-0371-7_54
https://doi.org/10.1007/88-470-0371-7_54
Publikováno v:
New Advances in Heart Failure and Atrial Fibrillation ISBN: 9788847021693
The prevalence of heart failure (HF) in Europe has recently been estimated to be on the order of 6.5 million individuals [1]. HF is the only major cardiovascular disease that is increasing in incidence [2] with approximately 580 000 new cases diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1807bbc42d389d5fe807bd824229a992
https://doi.org/10.1007/978-88-470-2087-0_41
https://doi.org/10.1007/978-88-470-2087-0_41
Autor:
S. Nisam
Publikováno v:
Cardiac Arrhythmias 2001 ISBN: 9788847021655
The very first trial aiming at evaluating the role of the implantable cardioverter defibrillator (ICD) as prophylaxis was the Multicenter Automatic Defibrillator Trial (MADIT), initiated by Moss and co-workers in 1990 [1]. MADIT demonstrated that ICD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62a9cf439b31cf6177d50a866a8962cc
https://doi.org/10.1007/978-88-470-2103-7_41
https://doi.org/10.1007/978-88-470-2103-7_41
Publikováno v:
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 4(4)
Despite the antiarrhythmic efficacy of amiodarone, a definitive correlation between amiodarone treatment and increased non-arrhythmic mortality in patients with heart failure and depressed ventricular function has been reported. Results from research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::322ebf37759c3466a34e695198662631
https://pubmed.ncbi.nlm.nih.gov/11141201
https://pubmed.ncbi.nlm.nih.gov/11141201
Publikováno v:
European heart journal. 21(24)
In the 20 years since Michel Mirowski and coworkers implanted an ICD into their first patient, the implantable cardioverter defibrillator (ICD) has become recognized as the therapy of first choice for managing patients at high risk of sudden cardiac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8a7b062642d3c846b4474dfd3769167
https://pubmed.ncbi.nlm.nih.gov/11102250
https://pubmed.ncbi.nlm.nih.gov/11102250
Autor:
S. Nisam
Publikováno v:
Cardiac Arrhythmias 1999-Vol.1 ISBN: 9788847000711
In the two decades since Mirowski and colleagues introduced the implantable cardioverter defibrillator (ICD) into clinical practice [1], multiple clinical studies have established ICD therapy as the treatment of choice compared to any alternative tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3a72bca4de7a866b44b88c9f739254d
https://doi.org/10.1007/978-88-470-2139-6_43
https://doi.org/10.1007/978-88-470-2139-6_43
Autor:
S, Nisam
Publikováno v:
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 2(4)
Several authors have made the intriguing observation that Implantable Cardioverter Defibrillators (ICD) appear not only to reduce sudden deaths, but also mortality due to non-arrhythmic causes. Studies have shown that this observation can not be attr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::83295f4c990b97c5786e9d59419cfd83
https://pubmed.ncbi.nlm.nih.gov/10027124
https://pubmed.ncbi.nlm.nih.gov/10027124
Autor:
S. Nisam
Publikováno v:
Cardiac Arrhythmias 1997 ISBN: 9788847022904
The implantable cardioverter defibrillator (ICD) has been established as the gold standard in terms of reducing sudden death resulting from lethal ventricular tachyarrhythmias [1, 2]. Many large series have shown that the rate of sudden death in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a19d1aca7544d8bae8b2dea5b86b2d51
https://doi.org/10.1007/978-88-470-2288-1_45
https://doi.org/10.1007/978-88-470-2288-1_45
Autor:
S, Nisam
Publikováno v:
The American journal of cardiology. 79(6A)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fbbf6c35dc684a50865eeb7d11063ad4
https://pubmed.ncbi.nlm.nih.gov/9080863
https://pubmed.ncbi.nlm.nih.gov/9080863